Center Hospitalier University Vaudois and Mount Sinai School of Medicine | Date: 2010-08-16
Pharmaceutical compositions and methods for treating cancer using CD44 antagonists are disclosed. In certain aspects, these pharmaceutical compositions and methods include treating a mammal having a cancer, such as glioma, colon cancer, breast cancer, prostate cancer, ovarian cancer, lung cancer, renal cell carcinoma, gastric cancer, esophageal cancer, head cancer, neck cancer, pancreatic cancer, or melanoma, with a CD44 fusion protein. These CD44 fusion proteins include CD44-Fc fusions and can be used to detect hyaluronan.
Center Hospitalier University Vaudois | Date: 2013-11-06
A medicament comprising a therapeutically effective amount of at least one omega-3 polyunsaturated fatty acid for use in the reduction and prevention of post-ischemic damages in patients undergoing elective surgery.
Center Hospitalier University Vaudois | Date: 2012-12-21
Center Hospitalier University Vaudois | Date: 2011-11-29
The invention relates to chemoembolization composition for anti-angiogenic agent delivery. The invention further relates to a method of preparing chemoembolization composition and to the use of chemoembolization composition in the method for treating solid tumour cancers.
Center Hospitalier University Vaudois and University of Bern | Date: 2010-07-29
The present invention relates to in vitro methods of determining a susceptibility to non-response to a hepatitis C treatment or a susceptibility to spontaneous hepatitis C clearance in a subject infected with hepatitis C.